Contract Services Clinical Research
Turning Frontline Reality Into Policy Action For Cancer Care In Asia
Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...
February 02, 2026 | Expert Insight
Kazia Therapeutics Advances First In Class Nuclear PD L1 Protein Degrader With Compelling Preclinical Evidence
Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, announced co...
February 02, 2026 | News
Fidēs Launches Science Led Imaging CRO Focused On Early Phase Clinical Decision Making
Fidēs announced its launch as a new imaging contract research organization (iCRO) designed specifically for early-phase clinical development, where imagin...
February 02, 2026 | News
Telix Pharmaceuticals Limited Doses First Patient In Japan Phase 3 Study Of Illuccix For Prostate Cancer Imaging
Telix Pharmaceuticals Limited announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for ...
January 30, 2026 | News
Drug Farm Secures FDA Fast Track Designation For First In Class ALPK1 Inhibitor DF 003 In ROSAH Syndrome
Drug Farm, a clinical-stage biopharmaceutical company advancing two novel small molecule drugs for ROSAH syndrome and hepatitis B, announced that the U.S. ...
January 30, 2026 | News
Simcere Pharmaceutical Group Licenses First In Class TL1A IL23p19 Bispecific Antibody To Boehringer Ingelheim For Inflammatory Bowel Disease
Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. Lice...
January 29, 2026 | News
Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer
Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...
January 29, 2026 | News
HKeyBio Introduces Translational Preclinical Strategy To Rethink Asthma And Allergy Drug Development
HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, announced a translational preclinical strategy, HKEY-AIRxTM1.0...
January 29, 2026 | News
Insilico Medicine Partners With Qilu Pharmaceutical Group To Advance AI Driven Cardiometabolic Drug Discovery
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceuti...
January 29, 2026 | News
Nuance Pharma’s Ohtuvayre NDA Accepted For Review In China For COPD Maintenance Treatment
Nuance Pharma announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA)...
January 28, 2026 | News
Corxel Pharmaceuticals Limited Secures Up To 287 Million Dollars In Series D1 Financing To Accelerate Global Cardiometabolic Pipeline
Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR ...
January 26, 2026 | News
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation Strengthening Clinical Biomarker Capabilities
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced that its San Diego laboratory has achieved Colle...
January 23, 2026 | News
Gene Solutions And Pangea Laboratory Partner To Advance US Clinical Validation Of Liquid Biopsy Tests
Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader ...
January 22, 2026 | News
Alteogen Signs Exclusive Global Licensing Deal With GSK Subsidiary Tesaro For ALT B4
Alteogen Inc. (KOSDAQ: 196170) announced that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK...
January 21, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
